FDA Approved: BUDESONIDE INHALATION — Supplemental Application (Amneal Pharmaceuticals of New York LLC)

View source ↗

Summary

FDA approved a supplemental application for Budesonide Inhalation by Amneal Pharmaceuticals of New York LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Budesonide Inhalation (Budesonide)

Snippet

SUPPL AP for BUDESONIDE INHALATION (BUDESONIDE)